Syndax Pharmaceuticals Inc — 貸借対照表 (NASDAQ:SNDX)

Financials

総資産 300.61 M449.66 M497.24 M612.88 M724.82 M529.71 M 負債合計 48.42 M41.29 M29.79 M58.68 M436.69 M465.08 M 純資産合計 252.19 M408.37 M467.45 M554.2 M288.12 M64.63 M 負債および純資産合計 300.61 M449.66 M497.24 M612.88 M724.82 M529.71 M 有利子負債合計 20.12 M19.89 M0—675.25 M-4.57 M 純負債 -272.65 M-418.86 M-474.66 M—-577.15 M-398.64 M

ニュース

Kura Oncology: Commercialization In AML Presents Asymmetric Upside (NASDAQ:KURA)

Syndax Pharmaceuticals, Inc. (SNDX) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Syndax Pharmaceuticalsがバークレイズ会議で戦略的成長に焦点

Syndax Pharmaceuticals at Barclays Conference: Strategic Growth Focus

Leerink会議でのSyndax：戦略的成長と収益性への道筋

Syndax at Leerink Conference: Strategic Growth and Profitability

Syndax Pharmaceuticalsの株価が22.91ドルで52週高値を記録

Syndax Pharmaceuticals stock hits 52-week high at $22.91

TD Cowen会議でのSyndax：戦略的成長と財務力

Syndax at TD Cowen Conference: Strategic Growth and Financial Strength

Stifel、医薬品売上を理由にSyndax Pharmaceuticalsの目標株価を引き上げ

Stifel raises Syndax Pharmaceuticals stock price target on drug sales